Wednesday, September 10, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Bitcoin

MicroStrategy Faces Setback as S&P 500 Exclusion Overshadows Bitcoin Strategy

Robert Sasse by Robert Sasse
September 10, 2025
in Bitcoin, Crypto Stocks, S&P 500
0
Strategy Stock
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

MicroStrategy’s bid to join the prestigious S&P 500 index has been denied, a significant blow to the enterprise software firm and its investors. Despite meeting the index’s formal criteria for market capitalization and recent profitability, the selection committee opted to include Robinhood and AppLovin instead. This decision dashes hopes for billions in potential passive investment inflows and raises questions about the sustainability of the company’s aggressive Bitcoin acquisition plan.

Persistent Bitcoin Accumulation Amid Shareholder Dilution

Undeterred by the setback, CEO Michael Saylor continues to execute the company’s core strategy. In the first week of September, MicroStrategy purchased an additional 1,955 Bitcoin for approximately $217.4 million. This latest acquisition brings the company’s total holdings to a staggering 638,460 BTC, with a market value of $47.17 billion. The average purchase price per coin stands at $73,880.

The purchase was primarily financed through the sale of equity, with $200.5 million raised from issuing new shares. This method of funding, while effective for accumulating Bitcoin, applies downward pressure on the stock by diluting the value for existing shareholders—a contributing factor to the share price’s recent weakness.

Index Snub Highlights Underlying Volatility Concerns

The S&P 500 committee’s decision appears to be rooted in risk assessment. Analysts suggest that MicroStrategy’s extreme stock volatility was a key deterrent. The stock boasts a beta of 3.83, meaning it tends to move nearly 4% for every 1% movement in the broader market. This level of volatility eclipses even that of other high-growth tech stocks like Nvidia and Tesla, presenting a risk profile seemingly too high for the committee’s comfort.

The exclusion is more than a symbolic snub; it has tangible financial consequences. The company is now set to miss out on an estimated $10 to $16 billion in potential passive investment that typically follows inclusion in the major index.

Should investors sell immediately? Or is it worth buying Strategy?

Mixed Analyst Sentiment Reflects Strategic Dilemma

Wall Street remains divided on MicroStrategy’s prospects. Benchmark recently reaffirmed its Buy rating with a $705 price target. Positive outlooks are also held by Canaccord Genuity and Mizuho. The average analyst price target for the stock sits around $564.

However, a fundamental challenge persists: the stock’s performance is inextricably linked to the price of Bitcoin. This tight correlation makes the company uniquely vulnerable to swings in the cryptocurrency market. Furthermore, investors are increasingly scrutinizing the significant premium of MicroStrategy’s market capitalization over the net asset value of its Bitcoin treasury.

Sustained Downtrend Despite Bullish Moves

Despite continuous Bitcoin buying and some supportive analyst views, MicroStrategy’s share price remains in a pronounced downtrend. This recent weakness coincides with the latest round of share issuance, highlighting the difficult position the company is in.

Its core strategy of aggressive Bitcoin accumulation is creating a feedback loop: each new purchase financed by equity dilutes shareholders and exerts additional selling pressure on the stock. MicroStrategy finds itself caught between its unwavering commitment to its Bitcoin strategy and the punishing realities of the equity market.

Ad

Strategy Stock: Buy or Sell?! New Strategy Analysis from September 10 delivers the answer:

The latest Strategy figures speak for themselves: Urgent action needed for Strategy investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from September 10.

Strategy: Buy or sell? Read more here...

Tags: Strategy
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

NVR Stock
Market Commentary

NVR Shares Decline Following Unexpected Labor Data Revision

September 10, 2025
Coinbase Stock
Blockchain

Coinbase’s Strategic Expansion Positions It for Market Dominance

September 10, 2025
Henry Stock
Banking & Insurance

Rewriting the Rules of Customer Loyalty: Jack Henry’s Stock-Based Rewards Strategy

September 9, 2025
Next Post
Marvell Technology Stock

Trust Recognition Fuels Marvell Technology's Market Momentum

Micron Stock

Micron Technology's AI-Driven Resurgence Captivates Markets

Meta Stock

Meta's $140 Million AI Vision Faces Regulatory Hurdles

Recommended

Healthcare cloud based

Select Healthcare Corporation Reports Impressive Q4 Results and Approves 108 Billion Buyback Program

2 years ago
Home Construction Stock Market Today

Concrete Pumping Holdings NASDAQ BBCP Prepares for Quarterly Earnings Report

2 years ago

Analyst Ratings and Price Targets for Eli Lilly Positive Outlook for Future Prospects

2 years ago
Biopharmaceutical

Title Lexaria Bioscience Corp Launches Innovative Study on DehydraTECHProcessed GLP1 Drugs and Cannabidiol for Diabetes and Weight Loss

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple BA BioNTech Broadcom C Coinbase DIS Eli Lilly Fiserv IBM Intel Iovance Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF MSFT NIO Nvidia Opendoor Oracle Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce SMCI Strategy Tesla TSLA Unitedhealth Viking Therapeutics
No Result
View All Result

Highlights

Leadership Transition at Farmer Mac Amid Market Volatility

Major Shareholder Exit Weighs on First Watch Restaurant Stock

Westlake Chemical Shares Decline Following Disappointing Quarterly Results

Ally Financial Sharpens Strategic Focus on Core Business Segments

NVR Shares Decline Following Unexpected Labor Data Revision

Ovintiv Emerges as a Quiet Performer in the Energy Sector

Trending

Hewlett Packard Enterprise Stock
Analysis

Regulatory Uncertainty Casts Shadow Over Hewlett Packard Enterprise’s Strong Performance

by Robert Sasse
September 10, 2025
0

Hewlett Packard Enterprise finds itself navigating turbulent waters as political challenges threaten to undermine its impressive quarterly...

HF Sinclair Stock

HF Sinclair Stock Surges as Refining Margins Hit Multi-Year Highs

September 10, 2025
Vigil Neuroscience Stock

Vigil Neuroscience Shares Trade in Narrow Range Ahead of Sanofi Acquisition

September 10, 2025
Federal Agricultural Mortgage Stock

Leadership Transition at Farmer Mac Amid Market Volatility

September 10, 2025
First Watch Restaurant Stock

Major Shareholder Exit Weighs on First Watch Restaurant Stock

September 10, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Regulatory Uncertainty Casts Shadow Over Hewlett Packard Enterprise’s Strong Performance September 10, 2025
  • HF Sinclair Stock Surges as Refining Margins Hit Multi-Year Highs September 10, 2025
  • Vigil Neuroscience Shares Trade in Narrow Range Ahead of Sanofi Acquisition September 10, 2025

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com